Orgenesis Inc. (ORGS)

0.4823 +0.0070 (+1.47%) As of 10:26AM EST. Market open.

Orgenesis Inc.

20271 Goldenrod Lane
Germantown, MD 20876
United States
480 659 6404
https://www.orgenesis.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 167

Key Executives

Name	Title	Pay	Exercised	Year Born
Ms. Vered Caplan M.Sc.	Chairperson of the Board, CEO & President	335.97k	875.75k	1969
Prof. Sarah Ferber Ph.D.	Founder & Chief Scientific Officer	268.32k	N/A	1954
Mr. Elliot Maltz CPA	Chief Financial Officer	N/A	N/A	1984
Dan Slonim	COO & GM of Orgenesis Israel	N/A	N/A	N/A
Dr. Shimon Hassin Ph.D.	Chief Technology Officer	N/A	N/A	N/A
Ms. Osher Partok Rheinisch	General Counsel & Compliance Officer	N/A	N/A	1972

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland.

Corporate Governance

Orgenesis Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.